Association Between Cancer and Sarcoidosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03844698|
Recruitment Status : Recruiting
First Posted : February 18, 2019
Last Update Posted : January 11, 2021
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||2000 participants|
|Official Title:||Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer|
|Actual Study Start Date :||July 4, 2019|
|Estimated Primary Completion Date :||February 5, 2022|
|Estimated Study Completion Date :||February 5, 2022|
Patients with Sarcoidosis and Cancer
These group of patients have a diagnosis of Sarcoidosis and Cancer on the Pathological Report.
- Pathology Proven Sarcoidosis In Patients with Cancer [ Time Frame: up to 10 years ]Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis.
- Cancer Cytogenetics and Sarcoidosis [ Time Frame: up to 10 years ]Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer.
- Treatment Requirement of Sarcoidosis [ Time Frame: up to 10 years ]Number of Participants With Sarcoidosis Events as Assessed by Requirement of Treatment with Steroid or Other Anti-Sarcoid Medications in Patients with Cancer.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03844698
|Contact: Mehdi Mirsaeidi, MD||(305)email@example.com|
|Contact: Camila Rodriguez||(305)243-2568|
|United States, Florida|
|University of Miami, Miller School of Medicine||Recruiting|
|Miami, Florida, United States, 33136|
|Contact: Mehdi Mirsaeidi, MD 305-243-2568 firstname.lastname@example.org|
|Contact: Adam Wanner, MD (305)243-2568 email@example.com|
|Principal Investigator: Mehdi Mirsaeidi, MD|
|Principal Investigator:||Mehdi Mirsaeidi, MD||University of Miami|